22 December 2024

Howe Street Reporter Title

Tag: Bioasis

  • Bioasis Technologies (BTI.V): To Invest or Not?

    Bioasis Technologies (BTI.V): To Invest or Not?

    For generations, people have suffered from brain cancers, neurodegenerative diseases, and metabolic disorders, and most drugs haven’t been optimized to deliver the right amount of dosage to the brain. One reason for that is the blood-brain barrier. That’s why in this episode, we take a look at Bioasis Technologies (TSX.V: BTI) (OTCQB: BIOAF). Their proprietary…

  • Bioasis Technologies (BTI.V): First Glance With Jody Vance (Ep 62)

    Bioasis Technologies (BTI.V): First Glance With Jody Vance (Ep 62)

    Dr. Mario Saltarelli, Director of Bioasis Technologies (BTI.V) talks about the company’s ground-breaking xB3 platform which allows therapeutic drugs to pass through the seemingly impenetrable blood-brain barrier, providing an effective treatment methodology for such neurological disorders as Alzheimer’s disease, Lewy Body Dementia and Parkinson’s. In short, Bioasis’ final frontier solution could very well revolutionize medical…